Alessandro Federico

Summary

Affiliation: Second University of Naples
Country: Italy

Publications

  1. ncbi Platelet aggregation is affected by nitrosothiols in patients with chronic hepatitis: in vivo and in vitro studies
    A Federico
    Inter University Research Centre on Foods, Nutrition and Gastrointestinal Tract, Gastroenterology School, 2nd University of Naples, Via Alcide De Gasperi 80, 84018 Scafati, Italy
    World J Gastroenterol 13:3677-83. 2007
  2. ncbi Heat shock protein 27 expression in patients with chronic liver damage
    Alessandro Federico
    Centro Interuniversitario per Ricerche su Alimenti, Nutrizione e Apparato Digerente CIRANAD, Cattedra di Gastroenterologia, II Universita di Napoli, Via Pansini 5, Napoli, Italy
    Immunobiology 209:729-35. 2005
  3. ncbi Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives
    A Federico
    2nd University of Naples, Gastroenterology Unit, Via Pansini 5, Naples 80131, Italy
    Dig Liver Dis 38:789-801. 2006
  4. ncbi Chronic inflammation and oxidative stress in human carcinogenesis
    Alessandro Federico
    Division of Gastroenterology, F Magrassi and A Lanzara Medical Surgical Department, Second University of Naples, Naples, Italy
    Int J Cancer 121:2381-6. 2007
  5. ncbi Emerging drugs for non-alcoholic fatty liver disease
    Alessandro Federico
    Via Alcide De Gasperi 80, 84018 Scafati SA, Italy
    Expert Opin Emerg Drugs 13:145-58. 2008
  6. ncbi The effect of a new symbiotic formulation on plasma levels and peripheral blood mononuclear cell expression of some pro-inflammatory cytokines in patients with ulcerative colitis: a pilot study
    A Federico
    Division of Gastroenterology, 2nd University of Naples, Naples, Italy
    Eur Rev Med Pharmacol Sci 13:285-93. 2009
  7. ncbi Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases
    Carmela Loguercio
    Department of Internistica Clinica e Sperimentale F Magrassi e A Lanzara, Inter University Research Center on Foods, Nutrition, and Gastrointestinal Tract CIRANAD, Second University of Naples, Naples, Italy
    J Clin Gastroenterol 39:540-3. 2005
  8. ncbi Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection
    Alessandro Federico
    Dipartimento Medico Chirurgico di Internistica Clinica e Sperimentale ed UOC di Gastroenterologia e, Napoli, Italy
    Gastroenterology 143:55-61.e1; quize e13-4. 2012
  9. ncbi The effect of a silybin-vitamin e-phospholipid complex on nonalcoholic fatty liver disease: a pilot study
    Carmela Loguercio
    Interuniversity Research Center on Foods, Nutrition and Gastrointestinal Tract CIRANAD, Unit of Gastroenterology, Second University of Naples, Naples, Italy
    Dig Dis Sci 52:2387-95. 2007
  10. ncbi Coeliac disease and C virus-related chronic hepatitis: a non association
    Antonietta Gerarda Gravina
    Department of Clinical and Experimental Medicine and Surgery F Magrassi e A Lanzara Hepato Gastroenterology Division and C, I, R, A, N, A, d, Second University of Naples, Via Pansini 5, Naples 80131, Italy
    BMC Res Notes 5:533. 2012

Collaborators

Detail Information

Publications27

  1. ncbi Platelet aggregation is affected by nitrosothiols in patients with chronic hepatitis: in vivo and in vitro studies
    A Federico
    Inter University Research Centre on Foods, Nutrition and Gastrointestinal Tract, Gastroenterology School, 2nd University of Naples, Via Alcide De Gasperi 80, 84018 Scafati, Italy
    World J Gastroenterol 13:3677-83. 2007
    ....
  2. ncbi Heat shock protein 27 expression in patients with chronic liver damage
    Alessandro Federico
    Centro Interuniversitario per Ricerche su Alimenti, Nutrizione e Apparato Digerente CIRANAD, Cattedra di Gastroenterologia, II Universita di Napoli, Via Pansini 5, Napoli, Italy
    Immunobiology 209:729-35. 2005
    ..The present data are the first showing that, particularly in conditions of enhanced oxidative stress, lymphomonocytes from liver disease patients present an increased expression of HSP27...
  3. ncbi Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives
    A Federico
    2nd University of Naples, Gastroenterology Unit, Via Pansini 5, Naples 80131, Italy
    Dig Liver Dis 38:789-801. 2006
    ....
  4. ncbi Chronic inflammation and oxidative stress in human carcinogenesis
    Alessandro Federico
    Division of Gastroenterology, F Magrassi and A Lanzara Medical Surgical Department, Second University of Naples, Naples, Italy
    Int J Cancer 121:2381-6. 2007
    ..This review focalizes some of these intricate events by discussing the relationships occurring among oxidative/nitrosative/metabolic stress, inflammation and cancer...
  5. ncbi Emerging drugs for non-alcoholic fatty liver disease
    Alessandro Federico
    Via Alcide De Gasperi 80, 84018 Scafati SA, Italy
    Expert Opin Emerg Drugs 13:145-58. 2008
    ..This last form may evolve to cirrhosis and hepatocellular carcinoma...
  6. ncbi The effect of a new symbiotic formulation on plasma levels and peripheral blood mononuclear cell expression of some pro-inflammatory cytokines in patients with ulcerative colitis: a pilot study
    A Federico
    Division of Gastroenterology, 2nd University of Naples, Naples, Italy
    Eur Rev Med Pharmacol Sci 13:285-93. 2009
    ..During intestinal inflammation white blood cells are recruited from the blood, and they represent the major contributors to tissue perpetuation of inflammation via their production of chemokines and proinflammatory cytokines...
  7. ncbi Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases
    Carmela Loguercio
    Department of Internistica Clinica e Sperimentale F Magrassi e A Lanzara, Inter University Research Center on Foods, Nutrition, and Gastrointestinal Tract CIRANAD, Second University of Naples, Naples, Italy
    J Clin Gastroenterol 39:540-3. 2005
    ..To evaluate whether chronic therapy with probiotics affects plasma levels of cytokines and oxidative/nitrosative stress parameters, as well as liver damage, in patients with various types of chronic liver disease...
  8. ncbi Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection
    Alessandro Federico
    Dipartimento Medico Chirurgico di Internistica Clinica e Sperimentale ed UOC di Gastroenterologia e, Napoli, Italy
    Gastroenterology 143:55-61.e1; quize e13-4. 2012
    ....
  9. ncbi The effect of a silybin-vitamin e-phospholipid complex on nonalcoholic fatty liver disease: a pilot study
    Carmela Loguercio
    Interuniversity Research Center on Foods, Nutrition and Gastrointestinal Tract CIRANAD, Unit of Gastroenterology, Second University of Naples, Naples, Italy
    Dig Dis Sci 52:2387-95. 2007
    ..Our data suggest that silybin conjugated with vitamin E and phospholipids could be used as a complementary approach to the treatment of patients with chronic liver damage...
  10. ncbi Coeliac disease and C virus-related chronic hepatitis: a non association
    Antonietta Gerarda Gravina
    Department of Clinical and Experimental Medicine and Surgery F Magrassi e A Lanzara Hepato Gastroenterology Division and C, I, R, A, N, A, d, Second University of Naples, Via Pansini 5, Naples 80131, Italy
    BMC Res Notes 5:533. 2012
    ..abstract:..
  11. ncbi Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage
    Rita Cariello
    Department of Experimental Medicine, Second University of Naples, Italy
    Dig Liver Dis 42:200-4. 2010
    ..Alteration in intestinal permeability may be an important factor in the pathogenesis of both the progression of some chronic liver diseases and the onset of some complications in patients with liver cirrhosis...
  12. ncbi Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial
    Carmela Loguercio
    Department F Magrassi e A Lanzara, Second University of Naples, 80131 Napoli, Italy
    Free Radic Biol Med 52:1658-65. 2012
    ..Treatment with RA but not P for 12 months was associated with improvement in liver enzymes, insulin resistance, and liver histology, without increases in body weight. These findings warrant further investigation...
  13. ncbi Oxidative stress in viral and alcoholic hepatitis
    Carmela Loguercio
    Gastroenterology School, 2nd University of Naples, and Inter University Research Center of Alimentary Intake, Nutrition and Digestive Tract CIRANAD, Naples, Italy
    Free Radic Biol Med 34:1-10. 2003
    ..quot; By enhancing the antioxidant ability of hepatocytes, through transgene vectors, one could counteract oxidative/nitrosative stress and, in this way, contribute to blocking the progression of liver disease...
  14. ncbi The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis
    Carmela Loguercio
    Department of Internal Medicine and Hepatogastroenterology, Second University of Naples, Naples, Italy
    Am J Gastroenterol 103:3159-66. 2008
    ..The aim of this study was to evaluate whether dietary composition affects the severity of liver damage and response to therapy in patients with HCV-related chronic hepatitis...
  15. ncbi Alcoholic beverages and gastric epithelial cell viability: effect on oxidative stress-induced damage
    C Loguercio
    Centro Interuniversitario di Ricerca su Alimenti, Nutrizione e Apparato Digerente Dipartimento Medico Chirurgico di Internistica Clinica e Sperimentale F Magrassi e A Lanzara, Seconda Universita di Napoli, Italia
    J Physiol Pharmacol 60:87-92. 2009
    ....
  16. ncbi [Effects of a new pharmacological complex (silybin + vitamin-E + phospholipids) on some markers of the metabolic syndrome and of liver fibrosis in patients with hepatic steatosis. Preliminary study]
    M Trappoliere
    Interuniversity Research Center on Foods Nutrition and Gastrointestinal Tract (CIRANAD, Unit of Gastroenterology, 2nd University of Naples, Naples, Italy
    Minerva Gastroenterol Dietol 51:193-9. 2005
    ..CONCLUSIONS: Our data have a role of suggestion to further evaluate, through a controlled trial, a possible therapeutic use of this new compound in the management of patients with NAFLD...
  17. ncbi Herbal products: benefits, limits, and applications in chronic liver disease
    Anna Del Prete
    Department of Clinical and Experimental Medicine, Interuniversity Research Centre on Food, Nutrition and the Gastrointestinal Tract CIRANAD, 2nd University of Naples, 80131 Naples, Italy
    Evid Based Complement Alternat Med 2012:837939. 2012
    ....
  18. ncbi Fat: a matter of disturbance for the immune system
    Alessandro Federico
    Section of Clinical Immunology, Department of Clinical and Experimental Medicine, Second University of Naples, Napoli, Italy
    World J Gastroenterol 16:4762-72. 2010
    ..This review discusses the role of fat as "a matter of disturbance for the immune system" with a focus on hepatic steatosis...
  19. ncbi Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial
    Marco Romano
    Dipartimento Medico, AziendaOspedaliera Universitaria, Seconda Universita di Napoli, Napoli, Italy
    Gut 59:1465-70. 2010
    ....
  20. ncbi Relationship of blood trace elements to liver damage, nutritional status, and oxidative stress in chronic nonalcoholic liver disease
    C Loguercio
    Centro Interuniversitario di Ricerche su Alimenti, Nutrizione e Apparato Digerente, , , Naples, Italy
    Biol Trace Elem Res 81:245-54. 2001
    ..The plasma Br level was higher in cirrhotics with respect to the control and chronic hepatitis groups...
  21. ncbi Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized study
    Angelo Andriulli
    Division of Gastroenterology, Casa Sollievo della Sofferenza Hospital, IRCCS, San Giovanni Rotondo, Italy
    J Clin Gastroenterol 42:S218-23. 2008
    ..Efficacy of symbiotics in patients with irritable bowel syndrome (IBS) remains unknown...
  22. ncbi Drinking habits and risk of altered liver enzymes in the general population of a rural area in Southern Italy
    C Loguercio
    Interuniversity Research Center on Foods, Nutrition and Gastrointestinal Tract CIRANAD, Unit of Gastroenterology, 2nd University of Naples, Naples, Italy
    Dig Liver Dis 39:748-52. 2007
    ....
  23. ncbi Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver
    C Loguercio
    School of Gastroenterology, Second University of Naples, Naples, Italy
    Dig Liver Dis 36:398-405. 2004
    ..To define the characteristics of the Italian patient presenting non-alcoholic fatty liver disease...
  24. ncbi Effects of selenium and zinc supplementation on nutritional status in patients with cancer of digestive tract
    A Federico
    Semeiotics and Clinical Methodology, II University of Naples, Naples, Italy
    Eur J Clin Nutr 55:293-7. 2001
    ..To evaluate the effect of oral administration of selenium and zinc tablets in patients with cancer of the digestive tract during chemotherapy...
  25. ncbi Alteration of haemostasis in non-metastatic gastric cancer
    P Di Micco
    Division of General Medicine and Hepatology, Second University of Naples, Italy
    Dig Liver Dis 33:546-50. 2001
    ..Cancer is one of the most common acquired causes of venous thromboembolism...
  26. ncbi Can dietary intake influence plasma levels of amino acids in liver cirrhosis?
    C Loguercio
    Interuniversity Research Centre on alimentary intake, Nutrition and Gastrointestinal Tract, Gastrointestinal School, Faculty of Medicine, 2nd University of Naples, Italy
    Dig Liver Dis 32:611-6. 2000
    ..Modifications in plasma amino acid patterns in cirrhotics are attributed to impaired liver function, being more evident in alcoholic than in viral cirrhosis...
  27. ncbi Gut-liver axis: a new point of attack to treat chronic liver damage?
    Carmela Loguercio
    Am J Gastroenterol 97:2144-6. 2002